Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGM - Nasdaq Real Time Price USD

Zentalis Pharmaceuticals, Inc. (ZNTL)

Compare
1.3900
-0.2000
(-12.58%)
At close: 4:00:01 PM EDT
1.3700
-0.02
(-1.44%)
After hours: 4:07:14 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 26.86M
Earnings -47.47M

Q1'24

Q2'24

Q3'24

Q4'24

-50M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.20
6.27 Average
1.3900 Current
10.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 77810
Avg. Estimate -0.61-0.62-2.25-2.32
Low Estimate -0.69-1.09-3.07-3.27
High Estimate -0.52-0.44-1.75-1.27
Year Ago EPS 0.14-1.24-2.28-2.25

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 9999
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales 40.56M--67.42M--
Sales Growth (year/est) -100.00%0.00%-100.00%0.00%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.74-0.83-0.87-0.68
EPS Actual 0.14-1.24-0.56-0.61
Difference 0.88-0.410.310.07
Surprise % 118.85%-49.95%35.69%9.96%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.61-0.62-2.25-2.32
7 Days Ago -0.66-0.69-2.46-2.35
30 Days Ago -0.66-0.69-2.46-2.35
60 Days Ago -0.8-0.81-2.93-2.63
90 Days Ago -0.8-0.81-2.93-2.63

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----23
Up Last 30 Days --222
Down Last 7 Days 2144
Down Last 30 Days 2--43

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ZNTL -533.52%50.29%1.27%-3.05%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Reiterates Wedbush: Neutral to Neutral 3/28/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/27/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/17/2025
Maintains Wells Fargo: Equal-Weight to Equal-Weight 1/30/2025
Maintains HC Wainwright & Co.: Buy to Buy 1/29/2025
Maintains UBS: Neutral to Neutral 1/28/2025

Related Tickers